已发表论文近20余篇，SCI收录论文12篇。其中以第一作者和通讯作者身份发表的SCI论文6篇，最高影响因子为6.747分。
作为主持人承担了国家自然科学青年基金1项和钱江人才计划项目1项，同时作为主要参与者承担国家级课题1项及浙江省自然科学基金重点项目1项等。
主要论文：
1. Kenzhen Lv,?Liqun Liu, Linbo Wang, Jiren Yu, Xiaojiao Liu, Yongxia Cheng, Minjun Dong, Rongyue Teng, Linjiao Wu, Peifen Fu, Wuguo Deng, *Wenxian Hu, Lisong Teng. Lin28 Mediates Paclitaxel Resistance by Modulating p21, Rb and Let-7a miRNA in Breast Cancer Cells, PLoS one, 7(7):e40008, 2012. （通讯作者）
2. He Y, Zhou Z, Hofstetter WL, Zhou Y, Hu W, Guo C, Wang L, Guo W, Pataer A, Correa AM, Lu Y, Wang J, Diao L, Byers LA, Wistuba II, Roth JA, Swisher SG, Heymach JV, Fang B. Aberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parameters. PLoS One, 7(2):e31087, 2012.
3. Yanbin Zhou, Wayne L. Hofstetter, Yong He, Wenxian Hu, Abujiang Pataer, Li Wang, Ji Wang, Yihong Zhou, Liping Yu, Bingliang Fang, Stephen G. Swisher. KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression. Cancer biology & therapy, 9(7):1-7, 2010.
4. Wenxian Hu, Wayne L, Hofstetter, Hong Li, Yanbin Zhou, Yong He, Abujiang Pataer, Li Wang, Keping Xie, Stephen G. Swisher and Bingliang Fang. Putative Tumor-Suppressive Function of Krüppel-Like Factor 4 in Primary Lung Carcinoma, Clinical Cancer Research, 15(18):5688-5695, 2009.
5. Hu W, Hofstetter W, Wei X, Guo W, Zhou Y, Pataer A, Li H, Fang B, Swisher SG. Double-Stranded RNA-Dependent Protein Kinase (PKR)-Dependent Apoptosis Induction by a Novel Small Compound. Journal of Pharmacology and Experimental Therapeutics, 328(3):866-872, 2009.
6. Hu W, Hofstetter W, Guo W, Li H, Pataer A, Peng HH, Guo ZS, Bartlett DL, Lin A, Swisher SG, Fang B. JNK-deficiency enhanced oncolytic vaccinia virus replication and blocked activation of double-stranded RNA-dependent protein Kinase. Cancer Gene Therapy, 15(9):616-624, 2008.
7. Hu Wenxian, Bartlett David L, Swisher Stephen G, Fang Bingliang. Redirecting adaptive immunity against foreign antigens to tumors for cancer therapy. Cancer biology & therapy, 6(11):1773-1779, 2007.
8. Pataer A, Hu W, Xiaolin L, Chada S, Roth JA, Hunt KK, Swisher SG. Adenoviral endoplasmic reticulum-targeted mda-7/interleukin-24 vector enhances human cancer cell killing. Molecular Cancer Therapeutics, 7(8):2528-2535, 2008.
